RAPID: Dashboard for COVID-19 Scientific Development

RAPID:COVID-19 科学发展仪表板

基本信息

  • 批准号:
    2028717
  • 负责人:
  • 金额:
    $ 19.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

Scientific discovery depends on the accumulation of knowledge. There are thousands of articles on any given topic, but no one person can read them all. This limitation is more important in the COVID-19 era, where dependable knowledge can mean the difference between life and death. This project works to improve methods related to the synthesis of scientific knowledge by developing a visual dashboard to summarize COVID-19 related research efforts. The main goal is to integrate a current COVID-19 literature dataset from the Whitehouse with a knowledge graph from PubMed and a drug discovery knowledge graph developed by Data2Discovery. This would enable the creation of the “Fight COVID-19 Dashboard,” a visualization tool that would centralize and visualize crucial, up to date data and scientific information related to COVID. This dashboard will help scientists and clinicians access and visualize the most recent information about COVID. Such information is also crucial for mining publications to generate research hypotheses and for identifying patterns of collaboration and innovation in scientific communication working to stop the spread of COVID. The PIs will make their data and the codes for constructing the dashboard open to the public to enable future efforts and enhance public trust in science through transparency.This project develops the Fight COVID-19 Dataset and visual dashboard to advance information science and aid in the fight against COVID-19. This is accomplished by integrating a current COVID-19 literature dataset from the White House with a knowledge graph from PubMed and a drug discovery knowledge graph interlinking dozens of publicly available databases in pre-clinical drug discovery. This dashboard will display COVID-19 related information, including: 1) the currently most mentioned biological entities (e.g., drugs, diseases, vaccines, genes) in PubMed and clinical trials; 2) the evolution of related biological entities according to PubMed literature and clinical trials; 3) the network connections of related biological entities; 4) the lists of active scientists, teams, and institutions and their research topics; and 5) collaborations of scientific teams to enable networking and inspire potential collaborations to fight against COVID-19. This research will advance textual analysis methods by moving beyond keyword analysis towards advanced understanding of the objects that the keywords indicate and propelling textual methods towards knowledge graph-based analysis. It also adds a longitudinal element to recent investigations of the evolving pathway of COVID-19 scientific studies related to bio entities and links the science of science to related research domains in new and potentially innovative ways.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
科学发现依赖于知识的积累。任何一个主题都有成千上万的文章,但没有一个人能读完它们。这种局限性在COVID-19时代更为重要,可靠的知识可能意味着生与死的区别。该项目致力于通过开发可视化仪表板来总结COVID-19相关研究工作,从而改进与科学知识综合相关的方法。主要目标是将来自怀特豪斯的当前COVID-19文献数据集与来自PubMed的知识图和Data 2Discovery开发的药物发现知识图整合在一起。这将有助于创建“抗击COVID-19仪表板”,这是一个可视化工具,将集中和可视化与COVID相关的关键、最新数据和科学信息。这个仪表板将帮助科学家和临床医生访问和可视化有关COVID的最新信息。这些信息对于矿业出版物产生研究假设以及确定科学传播中的合作和创新模式以阻止COVID的传播也至关重要。该项目旨在开发Fight COVID-19 Dataset和可视化仪表板,以推动信息科学的发展,并帮助抗击COVID-19。这是通过整合来自白宫的当前COVID-19文献数据集与来自PubMed的知识图谱以及在临床前药物发现中互连数十个公开数据库的药物发现知识图谱来实现的。此仪表板将显示COVID-19相关信息,包括:1)当前最常提及的生物实体(例如,药物、疾病、疫苗、基因); 2)根据PubMed文献和临床试验相关生物实体的演变; 3)相关生物实体的网络连接; 4)活跃科学家、团队和机构及其研究主题的列表;及5)科学团队的合作,以建立网络并激发潜在的合作以对抗COVID-19。这项研究将推进文本分析方法,超越关键字分析,对关键字所指示的对象进行深入理解,并将文本方法推向基于知识图的分析。该奖项还为最近对与生物实体相关的COVID-19科学研究的演变途径的调查增加了纵向元素,并以新的和潜在的创新方式将科学科学与相关研究领域联系起来。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Are we there yet? Analyzing scientific research related to COVID-19 drug repurposing
我们到了吗?
  • DOI:
    10.21203/rs.3.rs-80893/v1
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Park, N.;Ryu, H.;Ding, Y.;Yu, Q.;Bu, Y.;Wang, Q.;Yang, J.;& Song, M.
  • 通讯作者:
    & Song, M.
COVID-19 Portal: Profiling Researchers, Bio-entities, and Institutions
COVID-19 门户:研究人员、生物实体和机构概况
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wan, A.
  • 通讯作者:
    Wan, A.
Building the COVID-19 portal by integrating literature, clinical trials, and knowledge graphs
通过整合文献、临床试验和知识图构建 COVID-19 门户
  • DOI:
    10.1109/jcdl52503.2021.00040
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wan, A.
  • 通讯作者:
    Wan, A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ying Ding其他文献

Are exemption for strong brands: the influence of brand community rejection on brand evaluation
强势品牌是否可以豁免:品牌社区排斥对品牌评价的影响
Direct Citations between Citing Publications
引用出版物之间的直接引用
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yong Huang;Yi Bu;Ying Ding;Wei Lu
  • 通讯作者:
    Wei Lu
Analyzing Figures of Brain Images from Alzheimer's Disease Papers
分析阿尔茨海默病论文中的大脑图像
  • DOI:
    10.9776/17357
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Satoshi Tsutsui;Guilin Meng;Xiao;David J. Crandall;Ying Ding
  • 通讯作者:
    Ying Ding
Preparation and properties of bisphenol A sensor basedbr /on multiwalled carbon nanotubes/Li4Ti5O12-modified electrode
多壁碳纳米管/Li4Ti5O12修饰电极双酚A传感器的制备及性能
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Wei Sun;Ying Ding;Jie Liu;Weiming Liu;Yong Cheng;Lei Wang;Yuanxiang Gu
  • 通讯作者:
    Yuanxiang Gu
High prevalence of mupirocin-resistant staphylococci in a dialysis unit where mupirocin and chlorhexidine are routinely used for prevention of catheter-related infections.
在透析室中,莫匹罗星耐药葡萄球菌的患病率很高,其中莫匹罗星和氯己定常规用于预防导管相关感染。
  • DOI:
    10.1099/jmm.0.024539-0
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    3
  • 作者:
    B. Teo;S. J. Low;Ying Ding;T. Koh;L. Hsu
  • 通讯作者:
    L. Hsu

Ying Ding的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ying Ding', 18)}}的其他基金

Conference: Travel: III: Student Travel Support for 2024 ACM The Web Conference (TheWebConf)
会议:旅行:III:2024 年 ACM 网络会议 (TheWebConf) 的学生旅行支持
  • 批准号:
    2412369
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
I-Corps: Contextualization of Explainable Artificial Intelligence (AI) for Better Health
I-Corps:可解释人工智能 (AI) 的情境化以改善健康
  • 批准号:
    2331366
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
Collaborative Research: NSF-CSIRO: RESILIENCE: Graph Representation Learning for Fair Teaming in Crisis Response
合作研究:NSF-CSIRO:RESILIENCE:危机应对中公平团队的图表示学习
  • 批准号:
    2303038
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
I-Corps: Data2Discovery: DataHub Platform for Drug Safety Analysis
I-Corps:Data2Discovery:用于药物安全分析的 DataHub 平台
  • 批准号:
    1505374
  • 财政年份:
    2015
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
Workshop Proposal: Scholarly Evaluation Metrics: Opportunities and Challenges
研讨会提案:学术评估指标:机遇与挑战
  • 批准号:
    0936204
  • 财政年份:
    2009
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant

相似海外基金

Mintago Dynamic Pension Dashboard
Mintago 动态养老金仪表板
  • 批准号:
    83006747
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Innovation Loans
RAPID: Developing an Interactive Dashboard for Collecting and Curating Traffic Data after the March 26, 2024 Francis Scott Key Bridge Collapse
RAPID:开发交互式仪表板,用于收集和管理 2024 年 3 月 26 日 Francis Scott Key 大桥倒塌后的交通数据
  • 批准号:
    2426947
  • 财政年份:
    2024
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
SBIR Phase I: A Student Learning Dashboard
SBIR 第一阶段:学生学习仪表板
  • 批准号:
    2232826
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Standard Grant
Technology Readiness Self-Assessment Dashboard
技术准备情况自我评估仪表板
  • 批准号:
    10076441
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant for R&D
Developing and assessing the utility of a digital dashboard for surveillance of antimicrobial use in Nova Scotia
开发和评估用于监测新斯科舍省抗菌药物使用情况的数字仪表板的实用性
  • 批准号:
    478077
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Operating Grants
Development of a predictive model and electronic health record-based probability scoring system and dashboard for postoperative respiratory failure
开发术后呼吸衰竭的预测模型和基于电子健康记录的概率评分系统和仪表板
  • 批准号:
    10643357
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
Project DNA (Dashboard for Net-Zero Action)
DNA 项目(净零行动仪表板)
  • 批准号:
    10089002
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Collaborative R&D
Predictive modelling for HEI-Commercialisation Dashboard
HEI 商业化仪表板的预测建模
  • 批准号:
    10075732
  • 财政年份:
    2023
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant for R&D
Development of a Water Quality Data Dashboard
水质数据仪表板的开发
  • 批准号:
    572274-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.86万
  • 项目类别:
    University Undergraduate Student Research Awards
Glucose Optimization Through Technology Assisted Management (GO TEAM!):Use of a diabetes dashboard and community health worker to decrease disparities in technology use in pediatric T1D
通过技术辅助管理优化血糖(GO TEAM!):使用糖尿病仪表板和社区卫生工作者来减少儿科 T1D 技术使用的差异
  • 批准号:
    10708941
  • 财政年份:
    2022
  • 资助金额:
    $ 19.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了